Purpose: To evaluate retinal layer thickness with optical coherence tomography (OCT) in eyes with macula-off retinal detachment after silicone oil (SiO) or gas endotamponade. Procedures: Cross-sectional study of 40 eyes with macula-off rhegmatogenous retinal detachment that underwent vitrectomy. 20 eyes received SiO tamponade and 20 matched eyes received gas. 33 healthy fellow eyes served as controls. Macular spectral domain OCT was performed with automated layer detection in the 5 inner subfields of the Early Treatment Diabetic Retinopathy Study (ETDRS) map. Results: Comparing the SiO group with the gas group, the ganglion cell layer showed a significant thinning in all fields of the inner ring of the ETDRS map, the inner plexiform layer in the nasal, superior and temporal quadrants, and the outer plexiform layer in the nasal quadrant. Conclusions: Inner retinal layers in the fovea/parafovea were significantly thinner in the SiO group. Prospective studies are warranted to further elucidate possible retinal adverse effects of SiO tamponade.

Keywords:
Optical coherence tomography, Pars plana vitrectomy, Retinal detachment, Retinal layer thickness, Silicone oil tamponade
1.
Rizzo S, Barca F: Vitreous substitute and tamponade substances for microincision vitreoretinal surgery. Dev Ophthalmol 2014;54:92-101.
2.
Kleinberg TT, Tzekov RT, Stein L, Ravi N, Kaushal S: Vitreous substitutes: a comprehensive review. Surv Ophthalmol 2011;56:300-323.
3.
Foster WJ: Vitreous substitutes. Expert Rev Ophthalmol 2008;3:211-218.
4.
Pastor JC: Proliferative vitreoretinopathy: an overview. Surv Ophthalmol 1998;43:3-18.
5.
Gonvers M: Temporary silicone oil tamponade in the management of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol 1985;100:239-245.
6.
Federman JL, Schubert HD: Complications associated with the use of silicone oil in 150 eyes after retina-vitreous surgery. Ophthalmology 1988;95:870-876.
7.
Lucke KH, Foerster MH, Laqua H: Long-term results of vitrectomy and silicone oil in 500 cases of complicated retinal detachments. Am J Ophthalmol 1987;104:624-633.
8.
Leaver PK: Vitrectomy and fluid/silicone oil exchange for giant retinal tears: 10-year follow-up. Ger J Ophthalmol 1993;2:20-23.
9.
Inoue M, Iriyama A, Kadonosono K, Tamaki Y, Yanagi Y: Effects of perfluorocarbon liquids and silicone oil on human retinal pigment epithelial cells and retinal ganglion cells. Retina 2009;29:677-681.
10.
Giordano GG, Refojo MF: Silicone oils as vitreous substitutes. Prog Polym Sci 1998;23:509-532.
11.
Honda Y, Ueno S, Miura M, Yamaguchi H: Silicone oil particles trapped in the subretinal space: complications after substitution of the vitreous. Ophthalmologica 1986;192:1-5.
12.
Shields CL, Eagle RC Jr: Pseudo-Schnabel's cavernous degeneration of the optic nerve secondary to intraocular silicone oil. Arch Ophthalmol 1989;107:714.
13.
Pastor JC, Lopez MI, Saornil MA, Refojo MF: Intravitreal silicone and fluorosilicone oils: pathologic findings in rabbit eyes. Acta Ophthalmol 1992;70:651-658.
14.
Bambas B, Eckardt C, Vowinkel E, Kruse H: Toxic substances with silicone oil after intraocular injections. Ophthalmologe 1995;92:663-667.
15.
Papp A, Kiss EB, Timar O, Szabó E, Berecki A, Tóth J, Páli J: Long-term exposure of the rabbit eye to silicone oil causes optic nerve atrophy. Brain Res Bull 2007;74:130-133.
16.
Newsom RS, Johnston R, Sullivan PM, Aylward GB, Holder GE, Gregor ZJ: Sudden visual loss after removal of silicone oil. Retina 2004;24:871-877.
17.
Cazabon S, Groenewald C, Pearce IA, Wong D: Visual loss following removal of intraocular silicone oil. Br J Ophthalmol 2005;89:799-802.
18.
Herbert EN, Liew SH, Williamson TH: Visual loss after silicone oil removal. Br J Ophthalmol 2005;89:1667-1668.
19.
Williams PD, Fuller CG, Scott IU, Fuller DG, Flynn HW: Vision loss associated with the use and removal of intraocular silicone oil. Clin Ophthalmol 2008;2:955-959.
20.
Michel G, Meyer L, Naoun O: Sudden visual loss following silicone oil removal: three patients treated for giant retinal tear. J Fr Ophtalmol 2009;32:104-111.
21.
Christensen UC, La Cour M: Visual loss after use of intraocular silicone oil associated with thinning of inner retinal layers. Acta Ophthalmol 2012;90:733-737.
22.
Caramoy A, Droege KM, Kirchhof B, Fauser S: Retinal layers measurements in healthy eyes and in eyes receiving silicone oil-based endotamponade. Acta Ophthalmol 2014;92:e292-e297.
23.
Moya R, Chandra A, Banerjee PJ, Tsouris D, Ahmad N, Charteris DG: The incidence of unexplained visual loss following removal of silicone oil. Eye (Lond) 2015;29:1477-1482.
24.
Tode J, Purtskhvanidze K, Oppermann T, Hillenkamp J, Treumer F, Roider J: Vision loss under silicone oil tamponade. Graefes Arch Clin Exp Ophthalmol 2016;254:1465-1471.
25.
R Development Core Team: R: A Language and Environment for Statistical Computing. Vienna, R Foundation for Statistical Computing. http://www.R-project.org.
26.
Faude F, Francke M, Makarov F, Schuck J, Gärtner U, Reichelt W, Wiedemann P, Wolburg H, Reichenbach A: Experimental retinal detachment causes widespread and multilayered degeneration in rabbit retina. J Neurocytol 2001;30:379-390.
27.
dell'Omo R, Viggiano D, Giorgio D, Filippelli M, Di Iorio R, Calo R, Cardone M, Rinaldi M, dell'Omo E, Costagliola C: Restoration of foveal thickness and architecture after macula-off retinal detachment repair. Invest Ophthalmol Vis Sci 2015;56:1040-1050.
28.
Kominami A, Ueno S, Kominami T, Nakanishi A, Piao CH, Ra E, Yasuda S, Asami T, Terasaki H: Restoration of cone interdigitation zone associated with improvement of focal macular ERG after fovea-off rhegmatogenous retinal reattachment. Invest Ophthalmol Vis Sci 2016;57:1604-1611.
29.
Menke MN, Kowal JH, Dufour P, Wolf-Schnurrbusch U, Ceklic L, Framme C, Wolf S: Retinal layer measurements after successful macula-off retinal detachment repair using optical coherence tomography. Invest Ophthalmol Vis Sci 2014;55:6575-6579.
30.
Winter M, Eberhardt W, Scholz C, Reichenbach A: Failure of potassium siphoning by Müller cells: a new hypothesis of perfluorocarbon liquid-induced retinopathy. Invest Ophthalmol Vis Sci 2000;41:256-261.
31.
Asaria RH, Kon CH, Bunce C, Sethi CS, Limb GA, Khaw PT, Aylward GW, Charteris DG: Silicone oil concentrates fibrogenic growth factors in the retro-oil fluid. Br J Ophthalmol 2004;88:1439-1442.
32.
Kirchhof B, Tavakolian U, Paulmann H, Heimann K: Histopathological findings in eyes after silicone oil injection. Graefes Arch Clin Exp Ophthalmol 1986;224:34-37.
33.
Eckardt C, Nicolai U, Czank M, Schmidt D: Identification of silicone oil in the retina after intravitreal injection. Retina 1992;12(3 suppl):17-22.
34.
Knorr HL, Seltsam A, Holbach L, Naumann GO: Intraocular silicone oil tamponade. (A clinico-pathologic study of 36 enucleated eyes). Ophthalmologe 1996;93:130-138.
35.
Budde M, Cursiefen C, Holbach LM, Naumann GO: Silicone oil-associated optic nerve degeneration. Am J Ophthalmol 2001;131:392-394.
36.
Wickham L, Asaria RH, Alexander R, Luthert P, Charteris DG: Immunopathology of intraocular silicone oil: enucleated eyes. Br J Ophthalmol 2007;91:253-257.
37.
Wickham LJ, Asaria RH, Alexander R, Luthert P, Charteris DG: Immunopathology of intraocular silicone oil: retina and epiretinal membranes. Br J Ophthalmol 2007;91:258-262.
38.
Kiilgaard JF, Milea D, Løgager V, la Cour M: Cerebral migration of intraocular silicone oil: an MRI study. Acta Ophthalmol 2011;89:522-525.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.